NEW
Stock Screener with Intrinsic Value
BioNTech SE (BNTX)
Last Price$122.90.6%
Market Cap$29.5B
LTM Gross margin
84.3%
5Y avg
17.8%
Biotechnology industry
median
65.9%
Stock quality & Intrinsic value
6/10
0.3% undervalued
BioNTech SE Gross margin
Annual
Quarterly
LTM
Industry median
Company stand-alone
Crunching data... Almost there!
| Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 0.0% | (53.9%) | (22.9%) | (124.5%) | (46.0%) | 79.7% | 73.8% | 84.3% |
Overvalued or undervalued?
Check the intrinsic value for BNTX
and see if it's the right time to invest.
BioNTech SE (BNTX) Gross margin comparison analysis
Crunching data... Almost there!
BNTX key stats
USD
EUR
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
Loved by
investors
worldwide
investors
worldwide
10K+
Investors
use our platform
#1
Top value investing hub
with all necessary tools
1K+
Experienced investors
in our community
4.9
Average rating across
all rating platforms
FAQ
1) What is BioNTech SE's Gross margin?
As of today, Microsoft Corp's last 12-month Gross margin is 84.3%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Gross margin for BioNTech SE have been 70.6% over the past three years, and 18.7% over the past five years.
2) Is BioNTech SE's Gross margin Good?
As of today, BioNTech SE's Gross margin is 84.3%, which is higher than industry median of 65.9%. It indicates that BioNTech SE's Gross margin is Good.